Overview

The Effect of Dexmedetomidine in the Management of Pain After Uterine Artery Embolization

Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
0
Participant gender:
Female
Summary
The investigators examined the effect of dexmedetomidine in the management of pain after uterine artery embolization.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Severance Hospital
Treatments:
Dexmedetomidine
Criteria
Inclusion Criteria:

- age ≥ 20,

- ASA class I and II

Exclusion Criteria:

- bradycardia (< 45 bpm)

- heart block

- liver failure

- renal failure

- uncontrolled hypertension

- body mass index ≥ 30 kg/m2